CareRx (FRA:29C1) Other Financing: €-2.6 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:29C1 CareRx Corp FRA:29C1
66 GF Score
Price €2.04
GF Value €1.37
! 3 Warning Signs
View Full Analysis

What is CareRx Other Financing?

CareRx FRA:29C1 66 Other Financing is €-2.6 Mil as of Jun. 2026. GuruFocus rates FRA:29C1 with a GF Score™ of 66/100 and a GF Value™ of €1.37. The stock has 3 warning signs investors should review.

CareRx's Other Financing for the three months ended in Jun. 2026 was €-0.4 Mil.

CareRx's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was €-2.6 Mil.

CareRx Other Financing Historical Data

* Premium members only.

The historical data trend for CareRx's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CareRx Other Financing Chart

CareRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.43 -6.05 -7.66 -3.78 -2.03

CareRx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 0.00 -1.75 -0.42 -0.40
FRA:29C1
66GF Score
CareRx Corp FRA:29C1
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CareRx Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-2.6 Mil mean?
CareRx (FRA:29C1) has a Other Financing of €-2.6 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for CareRx and its competitors.
Is CareRx's Other Financing too high?
CareRx's current Other Financing is €-2.6 Mil. Overall, CareRx has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does CareRx's Other Financing compare to HCA and THC?
CareRx's Other Financing of €-2.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for CareRx and its competitors. CareRx's current Other Financing is €-2.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
CareRx (FRA:29C1) has a current Other Financing of €-2.6 Mil. The stock's GF Value™ is €1.37, compared to a current price of €2.04 — trading 48.9% above its estimated fair value. The current Other Financing is €-2.6 Mil. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For CareRx (FRA:29C1), the current Other Financing is €-2.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CareRx (FRA:29C1) Overvalued in 2026?

Based on GuruFocus' analysis, CareRx stock appears to be overvalued. The current stock price of €2.04 is trading 48.9% above its estimated GF Value™ of €1.37.

Key valuation signals for FRA:29C1:

  • Other Financing: €-2.6 Mil
  • GF Value™: €1.37 vs. price of €2.04 (48.9% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the FRA:29C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CareRx Business Description

Other Exchanges CHHHF:USACRRX:Canada
Address 320 Bay Street, Suite 1200, Toronto, ON, CAN, M5H 4A6
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score

Get the complete analysis for FRA:29C1

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.04
Price
€1.37
GF Value